TownSquare Capital’s Treace Medical Concepts TMCI Stock Holding History

TownSquare Capital’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,159	Closed	-$110K	–	1511
2025 Q1	$110K	Buy	+13,159	New	+$118K	﹤0.01%	1615

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TownSquare Capital's TMCI Position: Q2 2025 in Review

TownSquare Capital sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 13,159 shares — an estimated $110K sold.

TownSquare Capital first reported a position in TMCI in Q1 2025 and held it in 1 quarter. The position peaked at $110K in Q1 2025. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

TownSquare Capital reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
TownSquare Capital sold 13,159 Treace Medical Concepts shares in Q2 2025, an estimated $110K.
TownSquare Capital first reported a position in Treace Medical Concepts in Q1 2025 and held it in 1 quarter.
TownSquare Capital's Treace Medical Concepts position peaked at $110K in Q1 2025.
125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.